Healthcare IT & Genomics
Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.
Reports
Digital Pathology Market Intelligence Service - World - 2023
This Market Intelligence Service provides a rolling 12-month coverage of the global Digital Pathology market.
Imaging IT – Outpatient Settings - World - 2022
This is a brochure for a new market report on Imaging IT for Outpatient Settings – World – 2022, published in September 2022.
Real-World Data - A Strategic Analysis
This is a new study from Signify Research that will examine how the use of this clinically-derived data will emerge and evolve in the near future.
Imaging IT – Core Report - World - 2022
This is Signify Research’s 2022 report on the Imaging IT market, published in May 2022.
Imaging IT Market Intelligence Service - World - 2022/2023
This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunity for Imaging IT.
Laboratory Information Systems – World – 2022 - World - 2022
This is Signify Research’s new report on the world Laboratory Information Systems Market published in May 2022.
Analyst Insights
Signify Premium Insight: Perspectum’s Persuasive Value Proposition
Signify Premium Insights Subscription Required
February 2nd 2023 – Perspectum has recently secured $36m in Series C funding. It is a figure that, compared to its peers, is surprisingly low, particularly given Perspectum’s credentials. Is there a reason for this financial modesty?
Signify Premium Insight: Bayer Acquires Blackford as Platforms Become Priority
Signify Premium Insights Subscription Required
January 26th 2023 – Bayer announced it is acquiring AI platform provider Blackford Analysis. Bayer says it will allow Blackford to continue to operate independently, but, is this really the best option?
Signify Premium Insight: The Right Path for Fujifilm
Signify Premium Insights Subscription Required
January 19th 2023 – Fujifilm has taken its partnership with Inspirata a step further, acquiring the vendor’s digital pathology business. It’s a sensible step, but what broader benefits is it also likely to bring?
Signify Premium Insight: When Infrastructure isn’t Enough: Google Offers Algorithms to End-Users
Signify Premium Insights Subscription Required
January 12th 2023 – In its latest move in the medical imaging market, Google has licensed algorithms to AI vendors, Aidence and iCAD. The move gets Google’s products in customers’ hands, but are there any other benefits for the search giant?
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed?
12th January 2023 – Imogen Fitt of Signify Research attended the 9th Digital Pathology and AI Congress: Europe in December. In the article below she shares her thoughts on the conference with respect to recent industry discourse.